Bronchial Asthma Clinical Trial
Official title:
Control of Moderate or Severe Asthma With 160, 320 and 640 μg Ciclesonide/Day. A One-year Randomised, Double-blind, Multicenter Trial.
The aim of the trial is to investigate asthma control with 160 to 640 μg ciclesonide/day. Asthma control will be assessed by the Asthma Control Questionnaire (ACQ).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02934945 -
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
|
Phase 4 | |
| Completed |
NCT02561351 -
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
|
N/A | |
| Recruiting |
NCT01759472 -
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
|
N/A | |
| Completed |
NCT01918293 -
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult
|
N/A | |
| Completed |
NCT01203904 -
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
|
N/A | |
| Completed |
NCT01762917 -
Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
|
N/A | |
| Completed |
NCT00536731 -
Symbicort Rapihaler Therapeutic Equivalence Study
|
Phase 3 | |
| Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
| Completed |
NCT00930826 -
Childhood Asthma and Schooling: The Truth Unveiled
|
N/A | |
| Completed |
NCT00327028 -
Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
|
Phase 4 | |
| Completed |
NCT00413387 -
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
|
Phase 3 | |
| Completed |
NCT00950794 -
Study of Salmeterol (SN408D) for Adult Asthma
|
Phase 4 | |
| Completed |
NCT00153283 -
Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma
|
Phase 4 | |
| Completed |
NCT00142025 -
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
|
Phase 4 | |
| Completed |
NCT00153270 -
Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
|
Phase 4 | |
| Completed |
NCT03450434 -
XC8 in the Treatment of Patients With Bronchial Asthma
|
Phase 2 | |
| Recruiting |
NCT05189613 -
Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis
|
N/A | |
| Recruiting |
NCT04128111 -
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
|
||
| Completed |
NCT06326632 -
Comparative Effectiveness Study of Constant-Load Versus Graded Aerobic Exercise in Obese Children With Bronchial Asthma
|
N/A | |
| Completed |
NCT05088512 -
The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population
|